First Alzheimer’s drug to slow disease progression gets full FDA approval, likely triggering broader Medicare coverage
Originally Published: 06 JUL 23 06:47 ET Updated: 06 JUL 23 16:53 ET By Meg Tirrell, Nadia Kounang and Tami Luhby, CNN (CNN) — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease. The decision is expected to
Continue Reading